ArticleJournal for immunotherapy of cancer2026
SMAD7 drives natural killer cell antitumor activity through canonical TGF-β blockade and non-canonical transcriptional activation of STAT5A.
Jin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.